1 Market Overview of Endometriosis Treatment 1.1 Endometriosis Treatment Market Overview 1.1.1 Endometriosis Treatment Product Scope 1.1.2 Market Status and Outlook 1.2 Global Endometriosis Treatment Market Size Overview by Region 2015 VS 2020 VS 2026 1.3 Global Endometriosis Treatment Market Size by Region (2015-2026) 1.4 Global Endometriosis Treatment Historic Market Size by Region (2015-2020) 1.5 Global Endometriosis Treatment Market Size Forecast by Region (2021-2026) 1.6 Key Regions, Endometriosis Treatment Market Size YoY Growth (2015-2026) 1.6.1 North America Endometriosis Treatment Market Size YoY Growth (2015-2026) 1.6.2 Europe Endometriosis Treatment Market Size YoY Growth (2015-2026) 1.6.3 Asia-Pacific Endometriosis Treatment Market Size YoY Growth (2015-2026) 1.6.4 Latin America Endometriosis Treatment Market Size YoY Growth (2015-2026) 1.6.5 Middle East & Africa Endometriosis Treatment Market Size YoY Growth (2015-2026) 2 Endometriosis Treatment Market Overview by Type 2.1 Global Endometriosis Treatment Market Size by Type: 2015 VS 2020 VS 2026 2.2 Global Endometriosis Treatment Historic Market Size by Type (2015-2020) 2.3 Global Endometriosis Treatment Forecasted Market Size by Type (2021-2026) 2.4 Hormonal Contraceptives 2.5 Gonadotropin-releasingHormone(Gn-RH)Agonists 2.6 Progestin Therapy 2.7 Aromatase Inhibitors 3 Endometriosis Treatment Market Overview by Application 3.1 Global Endometriosis Treatment Market Size by Application: 2015 VS 2020 VS 2026 3.2 Global Endometriosis Treatment Historic Market Size by Application (2015-2020) 3.3 Global Endometriosis Treatment Forecasted Market Size by Application (2021-2026) 3.4 Hospital 3.5 Clinic 3.6 Other 4 Global Endometriosis Treatment Competition Analysis by Players 4.1 Global Endometriosis Treatment Market Size (Million US$) by Players (2015-2020) 4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Treatment as of 2019) 4.3 Date of Key Manufacturers Enter into Endometriosis Treatment Market 4.4 Global Top Players Endometriosis Treatment Headquarters and Area Served 4.5 Key Players Endometriosis Treatment Product Solution and Service 4.6 Competitive Status 4.6.1 Endometriosis Treatment Market Concentration Rate 4.6.2 Mergers & Acquisitions, Expansion Plans 5 Company (Top Players) Profiles and Key Data 5.1 AbbVie 5.1.1 AbbVie Profile 5.1.2 AbbVie Main Business 5.1.3 AbbVie Products, Services and Solutions 5.1.4 AbbVie Revenue (US$ Million) & (2015-2020) 5.1.5 AbbVie Recent Developments 5.2 Eli Lilly 5.2.1 Eli Lilly Profile 5.2.2 Eli Lilly Main Business and Company’s Total Revenue 5.2.3 Eli Lilly Products, Services and Solutions 5.2.4 Eli Lilly Revenue (US$ Million) (2015-2020) 5.2.5 Eli Lilly Recent Development and Reaction to Covid-19 5.3 AstraZeneca 5.5.1 AstraZeneca Profile 5.3.2 AstraZeneca Main Business 5.3.3 AstraZeneca Products, Services and Solutions 5.3.4 AstraZeneca Revenue (US$ Million) & (2015-2020) 5.3.5 Bayer Recent Developments 5.4 Bayer 5.4.1 Bayer Profile 5.4.2 Bayer Main Business 5.4.3 Bayer Products, Services and Solutions 5.4.4 Bayer Revenue (US$ Million) & (2015-2020) 5.4.5 Bayer Recent Developments 5.5 Astellas Pharma 5.5.1 Astellas Pharma Profile 5.5.2 Astellas Pharma Main Business 5.5.3 Astellas Pharma Products, Services and Solutions 5.5.4 Astellas Pharma Revenue (US$ Million) & (2015-2020) 5.5.5 Astellas Pharma Recent Developments 5.6 Meditrina Pharmaceuticals 5.6.1 Meditrina Pharmaceuticals Profile 5.6.2 Meditrina Pharmaceuticals Main Business 5.6.3 Meditrina Pharmaceuticals Products, Services and Solutions 5.6.4 Meditrina Pharmaceuticals Revenue (US$ Million) & (2015-2020) 5.6.5 Meditrina Pharmaceuticals Recent Developments 5.7 Pfizer 5.7.1 Pfizer Profile 5.7.2 Pfizer Main Business and Company’s Total Revenue 5.7.3 Pfizer Products, Services and Solutions 5.7.4 Pfizer Revenue (US$ Million) (2015-2020) 5.7.5 Pfizer Recent Development and Reaction to Covid-19 5.8 Neurocrine Biosciences 5.8.1 Neurocrine Biosciences Profile 5.8.2 Neurocrine Biosciences Main Business 5.8.3 Neurocrine Biosciences Products, Services and Solutions 5.8.4 Neurocrine Biosciences Revenue (US$ Million) & (2015-2020) 5.8.5 Neurocrine Biosciences Recent Developments 5.9 Takeda Pharmaceutical 5.9.1 Takeda Pharmaceutical Profile 5.9.2 Takeda Pharmaceutical Main Business 5.9.3 Takeda Pharmaceutical Products, Services and Solutions 5.9.4 Takeda Pharmaceutical Revenue (US$ Million) & (2015-2020) 5.9.5 Takeda Pharmaceutical Recent Developments 6 North America 6.1 North America Endometriosis Treatment Market Size by Country 6.2 United States 6.3 Canada 7 Europe 7.1 Europe Endometriosis Treatment Market Size by Country 7.2 Germany 7.3 France 7.4 U.K. 7.5 Italy 7.6 Russia 7.7 Nordic 7.8 Rest of Europe 8 Asia-Pacific 8.1 Asia-Pacific Endometriosis Treatment Market Size by Region 8.2 China 8.3 Japan 8.4 South Korea 8.5 Southeast Asia 8.6 India 8.7 Australia 8.8 Rest of Asia-Pacific 9 Latin America 9.1 Latin America Endometriosis Treatment Market Size by Country 9.2 Mexico 9.3 Brazil 9.4 Rest of Latin America 10 Middle East & Africa 10.1 Middle East & Africa Endometriosis Treatment Market Size by Country 10.2 Turkey 10.3 Saudi Arabia 10.4 UAE 10.5 Rest of Middle East & Africa 11 Endometriosis Treatment Market Dynamics 11.1 Industry Trends 11.2 Market Drivers 11.3 Market Challenges 11.4 Market Restraints 12 Research Finding /Conclusion 13 Methodology and Data Source 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Disclaimer 13.4 Author List

List of Tables Table 1. Global Market Endometriosis Treatment Market Size (US$ Million) Comparison by Region 2015 VS 2020 VS 2026 Table 2. Global Endometriosis Treatment Market Size by Region (2015-2020) (US$ Million) Table 3. Global Endometriosis Treatment Market Size Share by Region (2015-2020) Table 4. Global Endometriosis Treatment Forecasted Market Size by Region (2021-2026) (US$ Million) Table 5. Global Endometriosis Treatment Forecasted Market Size Share by Region (2021-2026) Table 6. Global Endometriosis Treatment Market Size (US$ Million) by Type: 2015 VS 2020 VS 2026 Table 7. Global Endometriosis Treatment Market Size by Type (2015-2020) (US$ Million) Table 8. Global Endometriosis Treatment Revenue Market Share by Type (2015-2020) Table 9. Global Endometriosis Treatment Forecasted Market Size by Type (2021-2026) (US$ Million) Table 10. Global Endometriosis Treatment Revenue Market Share by Type (2021-2026) Table 11. Global Endometriosis Treatment Market Size (US$ Million) by Application: 2015 VS 2020 VS 2026 Table 12. Global Endometriosis Treatment Market Size by Application (2015-2020) (US$ Million) Table 13. Global Endometriosis Treatment Revenue Market Share by Application (2015-2020) Table 14. Global Endometriosis Treatment Forecasted Market Size by Application (2021-2026) (US$ Million) Table 15. Global Endometriosis Treatment Revenue Market Share by Application (2021-2026) Table 16. Global Endometriosis Treatment Revenue (US$ Million) by Players (2015-2020) Table 17. Global Endometriosis Treatment Revenue Market Share by Players (2015-2020) Table 18. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Endometriosis Treatment as of 2019) Table 19. Date of Key Manufacturers Enter into Endometriosis Treatment Market Table 20. Global Endometriosis Treatment Top Players Headquarters and Area Served Table 21. Endometriosis Treatment Product Solution and Service Table 22. Global Endometriosis Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 23. Mergers & Acquisitions, Expansion Plans Table 24. AbbVie Basic Information List Table 25. AbbVie Description and Business Overview Table 26. AbbVie Endometriosis Treatment Products, Services and Solutions Table 27. Revenue (Million US$) in Endometriosis Treatment Business of AbbVie (2015-2020) Table 28. AbbVie Recent Developments Table 29. Eli Lilly Basic Information List Table 30. Eli Lilly Description and Business Overview Table 31. Eli Lilly Endometriosis Treatment Products, Services and Solutions Table 32. Revenue (Million US$) in Endometriosis Treatment Business of Eli Lilly (2015-2020) Table 33. Eli Lilly Recent Developments Table 34. AstraZeneca Basic Information List Table 35. AstraZeneca Description and Business Overview Table 36. AstraZeneca Endometriosis Treatment Products, Services and Solutions Table 37. Revenue (Million US$) in Endometriosis Treatment Business of AstraZeneca (2015-2020) Table 38. AstraZeneca Recent Developments Table 39. Bayer Basic Information List Table 40. Bayer Description and Business Overview Table 41. Bayer Endometriosis Treatment Products, Services and Solutions Table 42. Revenue (Million US$) in Endometriosis Treatment Business of Bayer (2015-2020) Table 43. Bayer Recent Developments Table 44. Astellas Pharma Basic Information List Table 45. Astellas Pharma Description and Business Overview Table 46. Astellas Pharma Endometriosis Treatment Products, Services and Solutions Table 47. Revenue (Million US$) in Endometriosis Treatment Business of Astellas Pharma (2015-2020) Table 48. Astellas Pharma Recent Developments Table 49. Meditrina Pharmaceuticals Basic Information List Table 50. Meditrina Pharmaceuticals Description and Business Overview Table 51. Meditrina Pharmaceuticals Endometriosis Treatment Products, Services and Solutions Table 52. Revenue (Million US$) in Endometriosis Treatment Business of Meditrina Pharmaceuticals (2015-2020) Table 53. Meditrina Pharmaceuticals Recent Developments Table 54. Pfizer Basic Information List Table 55. Pfizer Description and Business Overview Table 56. Pfizer Endometriosis Treatment Products, Services and Solutions Table 57. Revenue (Million US$) in Endometriosis Treatment Business of Pfizer (2015-2020) Table 58. Pfizer Recent Developments Table 59. Neurocrine Biosciences Basic Information List Table 60. Neurocrine Biosciences Description and Business Overview Table 61. Neurocrine Biosciences Endometriosis Treatment Products, Services and Solutions Table 62. Revenue (Million US$) in Endometriosis Treatment Business of Neurocrine Biosciences (2015-2020) Table 63. Neurocrine Biosciences Recent Developments Table 64. Takeda Pharmaceutical Basic Information List Table 65. Takeda Pharmaceutical Description and Business Overview Table 66. Takeda Pharmaceutical Endometriosis Treatment Products, Services and Solutions Table 67. Revenue (Million US$) in Endometriosis Treatment Business of Takeda Pharmaceutical (2015-2020) Table 68. Takeda Pharmaceutical Recent Developments Table 69. North America Endometriosis Treatment Market Size by Country (2015-2020) & (US$ Million) Table 70. North America Endometriosis Treatment Market Size Share by Country (2015-2020) Table 71. Europe Endometriosis Treatment Market Size by Country (2015-2020) & (US$ Million) Table 72. Europe Endometriosis Treatment Market Size Share by Country (2015-2020) Table 73. Asia-Pacific Endometriosis Treatment Market Size by Country (2015-2020) & (US$ Million) Table 74. Asia-Pacific Endometriosis Treatment Market Size Share by Country (2015-2020) (US$ Million) Table 75. Latin America Endometriosis Treatment Market Size by Country (2015-2020) & (US$ Million) Table 76. Latin America Endometriosis Treatment Market Size Share by Country (2015-2020) (US$ Million) Table 77. Middle East & Africa Endometriosis Treatment Market Size by Players (2015-2020) (US$ Million) Table 78. Middle East & Africa Endometriosis Treatment Market Size Share by Players (2015-2020) (US$ Million) Table 79. Endometriosis Treatment Market Trends Table 80. Endometriosis Treatment Market Drivers Table 81. Endometriosis Treatment Market Challenges Table 82. Endometriosis Treatment Market Restriants Table 83. Research Programs/Design for This Report Table 84. Key Data Information from Secondary Sources Table 85. Key Data Information from Primary Sources List of Figures Figure 1. Global Endometriosis Treatment Market Size Year-over-Year 2015-2026 & (US$ Million) Figure 2. Global Endometriosis Treatment Market Size (US$ Million), 2015 VS 2020VS 2026 Figure 3. Global Endometriosis Treatment Market Share by Regions: 2020 VS 2026 Figure 4. North America Endometriosis Treatment Market Size (US$ Million) Growth Rate (2015-2026) Figure 5. Europe Endometriosis Treatment Market Size (US$ Million) and Growth Rate (2015-2026) Figure 6. Asia-Pacific Endometriosis Treatment Market Size (US$ Million) and Growth Rate (2015-2026) Figure 7. Latin America Endometriosis Treatment Market Size (US$ Million) and Growth Rate (2015-2026) Figure 8. Middle East & Africa Endometriosis Treatment Market Size (US$ Million) and Growth Rate (2015-2026) Figure 9. Global Endometriosis Treatment Market Share by Type in 2020 & 2026 Figure 10. Hormonal Contraceptives Market Size (US$ Million) YoY Growth (2015-2026) Figure 11. Gonadotropin-releasingHormone(Gn-RH)Agonists Market Size (US$ Million) YoY Growth (2015-2026) Figure 12. Progestin Therapy Market Size (US$ Million) YoY Growth (2015-2026) Figure 13. Aromatase Inhibitors Market Size (US$ Million) YoY Growth (2015-2026) Figure 14. Global Endometriosis Treatment Market Size Share by Application in 2020 & 2026 Figure 15. Hospital Market Size (US$ Million) YoY Growth (2015-2026) Figure 16. Clinic Market Size (US$ Million) YoY Growth (2015-2026) Figure 17. Other Market Size (US$ Million) YoY Growth (2015-2026) Figure 18. Endometriosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 19. Global Top 5 and Top 10 Players Endometriosis Treatment Market Share in 2019 Figure 20. United States Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. Canada Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. Germany Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. France Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. U.K. Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Italy Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Russia Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Nordic Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. Rest of Europe Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. China Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. Japan Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. South Korea Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. Southeast Asia Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. India Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Australia Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Rest of Asia-Pacific Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Rest of Latin America Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Endometriosis Treatment Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Bottom-up and Top-down Approaches for This Report Figure 44. Data Triangulation

AbbVie Eli Lilly AstraZeneca Bayer Astellas Pharma Meditrina Pharmaceuticals Pfizer Neurocrine Biosciences Takeda Pharmaceutical